DE3014582C2 - - Google Patents

Info

Publication number
DE3014582C2
DE3014582C2 DE3014582A DE3014582A DE3014582C2 DE 3014582 C2 DE3014582 C2 DE 3014582C2 DE 3014582 A DE3014582 A DE 3014582A DE 3014582 A DE3014582 A DE 3014582A DE 3014582 C2 DE3014582 C2 DE 3014582C2
Authority
DE
Germany
Prior art keywords
ala
level
glu
leu
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3014582A
Other languages
German (de)
English (en)
Other versions
DE3014582A1 (de
Inventor
Bjoern Stockholm Se Luening
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BONNIERFOERETAGEN STOCKHOLM SE AB
Original Assignee
BONNIERFOERETAGEN STOCKHOLM SE AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BONNIERFOERETAGEN STOCKHOLM SE AB filed Critical BONNIERFOERETAGEN STOCKHOLM SE AB
Publication of DE3014582A1 publication Critical patent/DE3014582A1/de
Application granted granted Critical
Publication of DE3014582C2 publication Critical patent/DE3014582C2/de
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19803014582 1979-04-20 1980-04-16 Synthetisches antigenaktives polypeptid, verfahren zu dessen herstellung, das polypeptid enthaltendes antigenes mittel oder arzneimittel und deren verwendung Granted DE3014582A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7903505 1979-04-20

Publications (2)

Publication Number Publication Date
DE3014582A1 DE3014582A1 (de) 1980-10-30
DE3014582C2 true DE3014582C2 (en, 2012) 1990-11-08

Family

ID=20337858

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803014582 Granted DE3014582A1 (de) 1979-04-20 1980-04-16 Synthetisches antigenaktives polypeptid, verfahren zu dessen herstellung, das polypeptid enthaltendes antigenes mittel oder arzneimittel und deren verwendung

Country Status (9)

Country Link
US (1) US4327075A (en, 2012)
JP (2) JPS55141452A (en, 2012)
CA (1) CA1157465A (en, 2012)
CH (1) CH645880A5 (en, 2012)
DE (1) DE3014582A1 (en, 2012)
FR (1) FR2454436A1 (en, 2012)
GB (1) GB2047713B (en, 2012)
IT (1) IT1141277B (en, 2012)
SE (1) SE447263B (en, 2012)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA814637B (en) * 1980-07-17 1982-08-25 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
US4859765A (en) * 1983-10-17 1989-08-22 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
FI895699A0 (fi) * 1988-03-29 1989-11-28 Scripps Clinic Res Diagnostiska foerfaranden och system foer kvantisering av apo ai.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485810A (en) * 1967-07-24 1969-12-23 Lilly Co Eli Novel amino acid protecting groups
US4028315A (en) * 1970-10-16 1977-06-07 E. R. Squibb & Sons, Inc. Solid phase synthesis of peptides
US3912711A (en) * 1972-07-03 1975-10-14 Susan E Leeman Synthetically produced undecapeptide, Substance P
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
US3915949A (en) * 1974-02-12 1975-10-28 Armour Pharma Solid phase synthesis of ACTH
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
US4062746A (en) * 1975-05-07 1977-12-13 Wisconsin Alumni Research Foundation Solid phase synthesis of protected peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4031070A (en) * 1976-03-01 1977-06-21 Parke, Davis & Company Tetrapeptides
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization

Also Published As

Publication number Publication date
CH645880A5 (de) 1984-10-31
JPH0240986B2 (en, 2012) 1990-09-14
DE3014582A1 (de) 1980-10-30
JPS55141452A (en) 1980-11-05
SE447263B (sv) 1986-11-03
SE8002726L (sv) 1980-10-21
JPS6364440B2 (en, 2012) 1988-12-12
CA1157465A (en) 1983-11-22
IT8021411A0 (it) 1980-04-16
IT1141277B (it) 1986-10-01
JPH01173871A (ja) 1989-07-10
GB2047713A (en) 1980-12-03
FR2454436B1 (en, 2012) 1983-06-10
US4327075A (en) 1982-04-27
GB2047713B (en) 1983-02-02
FR2454436A1 (fr) 1980-11-14

Similar Documents

Publication Publication Date Title
DE2717741C2 (en, 2012)
DE69020143T2 (de) Verfahren zur verwendung und herstellung von peptiden.
EP0783522B1 (de) PEPTIDE AUS DER SEQUENZ DES hPTH (1-37)
DE69432629T2 (de) Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
DE3586772T2 (de) Verfahren zur bestimmung von mimotopen.
DE3211263C2 (en, 2012)
DE3586616T2 (de) Verfahren zur verhuetung und induktion menschlicher plaettchen-aggregation.
DE2858718C2 (en, 2012)
EP0379949A2 (de) Verfahren zur Bestimmung von HIV-Antikörpern
DE69228277T2 (de) PACAP-Derivate mit c-AMP-produzierenden Eigenschaften
DE69132864T2 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
DE3120312C2 (de) Verfahren zur Herstellung von Darm-Glucagon-Antigenen und deren Verwendung
DE3014582C2 (en, 2012)
DE69325987T2 (de) Verfahren zur Herstellung von Lachs-Calcitonin
DE2364883C2 (de) Des-Lys↑2↑↑9↑-Ala↑3↑↑0↑-Schweine- und -Rinderinsulin, Verfahren zu deren Herstellung und diese Insuline enthaltende injizierbare Präparate
DE69737329T2 (de) Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i
DE2804566C2 (de) Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3650035T2 (de) THF-Zusammensetzungen.
EP1012175A1 (de) Peptid mit affinität zu gerinnungsfaktor viii
DE69014042T2 (de) Verfahren zur Herstellung von menschlichem Osteocalcin.
DE60033783T2 (de) Regulatorische/entfaltende peptide von ezrin
DE68919758T2 (de) Antikörper gegen Fibrin, Immunogen zur Herstellung desselben, Verfahren zur Bestimmung von Fibrin und pharmazeutisches Präparat auf Basis der Antikörper.
DE68925365T2 (de) PEPTIDE, DIE EPITOPE AUF R-IFN-BETA REPRÄSENTIEREN, ANTIKöRPER DAGEGEN, UND IHRE ANWENDUNG
CH640217A5 (en) Polypeptides, their preparation and pharmaceutical preparations
DE69613086T2 (de) Antigenen Peptide mit Glycinsubstitution

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee